Director/PDMR Shareholding

Summary by AI ^BETAClose X

On May 1, 2026, 3i Group plc announced that its Directors and persons discharging managerial responsibilities acquired ordinary shares through the 3i Group Share Incentive Plan. Each of the five listed Directors/PDMRs purchased 70 Partnership Shares at 2572.33333 pence per share and received 140 Matching Shares for nil consideration, resulting in a total of 210 shares per individual. These transactions, which occurred outside a trading venue, were notified to the company on May 1, 2026.

Disclaimer*

3i Group PLC

01 May 2026

Director/PDMR Shareholdings

UK Market Abuse Regulation Article 19

Pursuant to the rules of The 3i Group Share Incentive Plan, on 30 April 2026 each of the Directors/persons discharging managerial responsibilities ("PDMRs") of 3i Group plc (the "Company") (LEI: 35GDVHRBMFE7NWATNM84) listed below became beneficially interested in the total number of ordinary shares of 73 19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") shown against their name below, such Shares consisting of:

(a)

Partnership Shares, which were purchased at a subscription price of 2572.33333 pence per Share; and

(b)

Matching Shares, which were awarded for nil consideration.

	Partnership Shares	Matching Shares	Total Shares
Directors/PDMRs
K J Dunn	70	140	210
J H Halai	70	140	210
A Lissaman	70	140	210
J Marie	70	140	210
B Sottomayor	70	140	210

The Company was notified of the above transactions on 1 May 2026. These transactions took place outside a Trading Venue.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END